HealthDay - Trial Set to See if Drug Can Prevent Alzheimer's
Researchers are preparing to test an experimental drug in people genetically primed to develop Alzheimer's disease. The best-scenario hope is that the drug will lead to a way of preventing the progressive brain-wasting disease, and to a better understanding of its destructive processes. Experts on Alzheimer's disease welcomed the announcement of the drug trial. "This strategy is our best chance of success at Alzheimer's disease," said Dr. Sam Gandy, associate director of the Alzheimer's Disease Research Center at Mount Sinai School of Medicine and director of Mount Sinai's Center for Cognitive Health, in New York City. "The main challenges are how to identify who is on their way to [Alzheimer's disease], how early we need to begin prior to symptoms, and how long we will have to run the trial before we can see whether the drug delays onset."
- Dr. Sam Gandy, Professor, Neurology, Psychiatry, Associate Director of the Mount Sinai Alzheimer's Disease Research Center, Mount Sinai School of Medicine
Learn more: http://health.usnews.com/health-news/news/articles/2012/05/15/trial-set-to-see-if-drug-can-prevent-alzheimers